Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

CNFXX vs. RIMOX: which is better?

Bottom line

CNFXX vs RIMOX: the short answer

CNFXX (City National Rochdale Government Money Market Fund) and RIMOX (City National Rochdale Fixed Income Opportunities Fund) are both money market funds.

CNFXX is cheaper at 0.79% vs 1.21% — a difference of $42 a year per $10,000 invested.

Updated Nov 19, 2026

CNFXX vs RIMOX side by side

CNFXXRIMOX
TypeMoney market fundMutual fund
Fund familyCity National RochdaleCity National Rochdale
CategoryMoney MarketCore / Intermediate Bond
Expense ratio0.79%1.21%
Annual cost per $10k$79$121
10-yr cost on $10k (prospectus)$1,216$1,466
Max front load——
12b-1 fee0.45%0.25%
1-yr return+3.5%—
5-yr return (annualized)+2.7%—
10-yr return (annualized)+1.6%—
Best quarter—+14.6%
Worst quarter—−17.7%
Net assets (fund)—$1.5B
Number of holdings—942
Portfolio turnover—4%
Returns as ofDec 31, 2025—

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

CNFXX and RIMOX share none of their top holdings.

CNFXX top 10

    RIMOX top 10

    1. N/a — 5.55%
    2. N/a — 4.89%
    3. N/a — 2.71%
    4. United States of America — 2.36%
    5. United States of America — 2.02%
    6. Armada Euro Clo Designated Activity Company — 1.06%
    7. N/a — 1.06%
    8. N/a — 1.04%
    9. N/a — 0.83%
    10. N/a — 0.82%

    FAQ

    What is the difference between CNFXX and RIMOX?
    CNFXX (City National Rochdale Government Money Market Fund) and RIMOX (City National Rochdale Fixed Income Opportunities Fund) are both money market funds. CNFXX is cheaper at 0.79% vs 1.21% — a difference of $42 a year per $10,000 invested.
    Which is cheaper, CNFXX or RIMOX?
    CNFXX has the lower expense ratio (0.79%).
    Should I own both CNFXX and RIMOX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.